UK

Umakanth Katta

Active Director Director DIN 07438554
DIN 07438554 First appointment Feb 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 14 active board seats
Past companies 3 historical roles
Total affiliations 17 Since Feb 2016
Shareholding value •••• Premium profile

About Umakanth Katta

Data last updated:

Umakanth Katta is a Director at Vista Pharmaceuticals Ltd (since 2020), Director at Anuktha West Wave Developers Private Limited (since 2024) and Director at Hyperbrainz Media Private Limited (since 2024), and holds 11 more current directorships. The companies operate in Pharma, Real Estate and Construction and Information Technology. The 2 current companies with reported revenue have a combined latest revenue of ₹10.72 Cr; the largest is Vista Pharmaceuticals Ltd at ₹10.62 Cr (FY 2024). Earlier, Umakanth Katta was a Director at Anuktha Galaxica Developers Private Limited (2020–2022) and Director at Prosperiti Homes Private Limited (2020–2022) and 1 more.

DIN 07438554
Primary Designation Director
Industry Pharma
First Appointment 15 Feb 2016
Oldest Company Age 35 yrs
Largest company Vista Pharmaceuticals Ltd · ₹10.62 Cr (FY 2024)
Combined revenue ₹10.72 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vista Pharmaceuticals Ltd L24239TG1991PLC012264
Director13 Jul 20201991₹10.62 Cr (FY 2024)Active
Director25 Nov 20242020₹9.6 Lakh (FY 2024)Active
Hyperbrainz Media Private Limited U74999TG2018PTC126783
Director22 May 20242018Active
Partner14 Feb 20242024Active
Designated Partner08 Dec 20232023Active
Designated Partner01 Jun 20232023Active
Designated Partner17 Jun 20222022Active
Designated Partner09 Apr 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Nov 20202020Active
Prosperiti Homes Private Limited U45309TG2020PTC145622
Director05 Nov 20202020₹55.88 Cr (FY 2025)Active
Designated Partner02 Aug 20182018Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Umakanth Katta

NameDINCompanyDesignation
Barkha JainVista Pharmaceuticals LtdCompany Secretary
Dhananjaya Alli00610909Vista Pharmaceuticals LtdWhole-Time Director
Divakar Reddy Yerrabommanahalli08574891Vista Pharmaceuticals LtdDirector
Divya Bhavani Chakravarthula08074187Vista Pharmaceuticals LtdDirector
Mallem Hanumantha Rao00129311Vista Pharmaceuticals LtdDirector
Murali Meraga02537507Vista Pharmaceuticals LtdManaging Director
Pavan Sathvik Gilaka09733182Vista Pharmaceuticals LtdWhole-Time Director
Stanley Prabhakar Reddy07614532Vista Pharmaceuticals LtdDirector
Suneel PachipalaVista Pharmaceuticals LtdCfo
Umesh Virupakah Banakar08074091Vista Pharmaceuticals LtdDirector
Siva Prasad Kyasa09691324Anuktha West Wave Developers Private LimitedAdditional Director
Sudhir Pothula06971624Hyperbrainz Media Private LimitedDirector
Udaya Kumar Coimbatore Svarnalatha06971627Hyperbrainz Media Private LimitedDirector
Venu Gopal Vabbilisetty07041483Hyperbrainz Media Private Limited , Anuktha Ikigai City Developers Private Limited and 4 moreDirector
Gajjala Mallikarjuna Reddy03461102Livbig Trading And Marketing LlpDesignated Partner
Jaya Pavan Gummadi09517357Livbig Trading And Marketing Llp , Anuktha Nirvi Ventures LlpDesignated Partner
Sharada Gangarapu07438560Southern Mansions Llp , South Saga Mansions Llp and 1 moreDesignated Partner
Srinivasa Rao Deevela08625345South Saga Mansions LlpDesignated Partner
Ram Mohan Doddi08097198Nanyatha Estates LlpDesignated Partner
Raghavendra Rao Challagonda10035079Anuktha Ikigai City Developers Private LimitedDirector
Ravichandra Rao Challagonda11333258Anuktha West Sky Developers Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Nanyatha Estates Llp
Vipinam Avenues Llp
Vista Pharmaceuticals Ltd
Anuktha Developers Private Limited
Premium access

Shareholding and investment profile for Umakanth Katta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Umakanth Katta

Umakanth Katta currently holds 14 directorships: Vista Pharmaceuticals Ltd (Director, since 13 Jul 2020, revenue ₹10.62 Cr (FY 2024)); Anuktha West Wave Developers Private Limited (Director, since 25 Nov 2024, revenue ₹9.6 Lakh (FY 2024)); Hyperbrainz Media Private Limited (Director, since 22 May 2024); Livbig Trading And Marketing Llp (Partner, since 14 Feb 2024); Southern Mansions Llp (Designated Partner, since 08 Dec 2023); and 9 more.

Umakanth Katta was first appointed on 15 Feb 2016 as Director at Purnachandra Infrastructure Private Limited. The most recent appointment on record is 25 Nov 2024 at Anuktha West Wave Developers Private Limited.

The 2 current companies of Umakanth Katta that report revenue have a combined latest revenue of ₹10.72 Cr: Vista Pharmaceuticals Ltd ₹10.62 Cr (FY 2024); Anuktha West Wave Developers Private Limited ₹9.6 Lakh (FY 2024).

Umakanth Katta held 3 earlier board appointments: Anuktha Galaxica Developers Private Limited (Director, 05 Nov 2020 to 15 Sep 2022); Prosperiti Homes Private Limited (Director, 05 Nov 2020 to 15 Sep 2022); Aur Vridhi Avenues Llp (Designated Partner, 02 Aug 2018 to 20 Feb 2019).

The current boards of Umakanth Katta's companies include Barkha Jain (Vista Pharmaceuticals Ltd), Dhananjaya Alli (Vista Pharmaceuticals Ltd), Divakar Reddy Yerrabommanahalli (Vista Pharmaceuticals Ltd), Divya Bhavani Chakravarthula (Vista Pharmaceuticals Ltd), Mallem Hanumantha Rao (Vista Pharmaceuticals Ltd), Murali Meraga (Vista Pharmaceuticals Ltd), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available